Genesis Healthcare, Inc.
GENN
$0.0002
$0.000.00%
| 12/31/2020 | 09/30/2020 | 06/30/2020 | 03/31/2020 | 12/31/2019 | |
|---|---|---|---|---|---|
| Revenue | -14.45% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.45% | -- | -- | -- | -- |
| Cost of Revenue | -9.21% | -- | -- | -- | -- |
| Gross Profit | -20.70% | -- | -- | -- | -- |
| SG&A Expenses | 3.08% | -- | -- | -- | -- |
| Depreciation & Amortization | -12.44% | -- | -- | -- | -- |
| Other Operating Expenses | -8.44% | -- | -- | -- | -- |
| Total Operating Expenses | -7.50% | -- | -- | -- | -- |
| Operating Income | -626.05% | -- | -- | -- | -- |
| Income Before Tax | -1,259.27% | -- | -- | -- | -- |
| Income Tax Expenses | -305.82% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,483.02% | -- | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 521.47% | -- | -- | -- | -- |
| Net Income | -503.33% | -- | -- | -- | -- |
| EBIT | -626.05% | -- | -- | -- | -- |
| EBITDA | -192.83% | -- | -- | -- | -- |
| EPS Basic | -509.13% | -- | -- | -- | -- |
| Normalized Basic EPS | -182.37% | -- | -- | -- | -- |
| EPS Diluted | -1,632.55% | -- | -- | -- | -- |
| Normalized Diluted EPS | -235.98% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 4.27% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 3.94% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
